Oncolytics Biotech Inc. (ONCY)
-NasdaqCM 2.64 
0.04(1.49%) May 17, 3:59PM EDT
| Prev Close: | 2.68 |
|---|
| Open: | 2.67 |
|---|
| Bid: | 2.42 x 100 |
|---|
| Ask: | 3.84 x 100 |
|---|
| 1y Target Est: | 6.47 |
|---|
| Beta: | 2.2 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2.62 - 2.68 |
|---|
| 52wk Range: | 1.60 - 4.93 |
|---|
| Volume: | 171,063 |
|---|
| Avg Vol (3m): | 464,541 |
|---|
| Market Cap: | 223.76M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.46 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care ConferenceCNW Group(Tue, May 14)
- Media Advisory - Oncolytics Biotech® Inc. to Present at Bank of America Merrill Lynch Health Care ConferencePR Newswire(Tue, May 14)
- Oncolytics Biotech's CEO Presents at 2013 Annual Meeting of Shareholders Conference (Transcript)at Seeking Alpha(Sat, May 11)
- Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of ShareholdersCNW Group(Fri, May 10)
- Oncolytics Biotech® Inc. Announces Director Election Results from its Annual and Special Meeting of ShareholdersPR Newswire(Fri, May 10)
- Oncolytics Biotech® Inc. Announces First Quarter 2013 ResultsCNW Group(Thu, May 9)
- Oncolytics Biotech® Inc. Announces First Quarter 2013 ResultsPR Newswire(Thu, May 9)
- Oncolytics Biotech® Inc. Announces Details of 2013 Annual and Special Meeting of ShareholdersCNW Group(Mon, May 6)
- Oncolytics Biotech® Inc. Announces Details of 2013 Annual and Special Meeting of ShareholdersPR Newswire(Mon, May 6)
- Media Advisory - Oncolytics Biotech® Inc. to Present at 12th Annual Needham Healthcare ConferenceCNW Group(Mon, Apr 29)
- Media Advisory - Oncolytics Biotech® Inc. to Present at 12th Annual Needham Healthcare ConferencePR Newswire(Mon, Apr 29)
- 3 Biotech Stocks You Can't Ignoreat Motley Fool(Wed, Apr 10)
- Oncolytics: A Failing Biopharma, Or An Opportune Buy?at Seeking Alpha(Mon, Apr 8)
- Biotech Stock Mailbag: MannKind, Ariad, Oncolytics Biotechat TheStreet(Fri, Apr 5)
- ONCOLYTICS BIOTECH INC FinancialsEDGAR Online Financials(Fri, Mar 29)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.33 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.09 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
View More